Start free

PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Blue Cross & Blue Shield of MississippiAll Plans · Coverage · Medical Policy · UrologyMedium impact

Permanently Implanted Prostatic Devices for Benign Prostatic Hyperplasia

Effective date
Not stated in the notice
Identified
Sep 5, 2026

Summary

Blue Cross Blue Shield Association medical policy 7.01.181 considers permanently implanted prostatic stent devices, such as the ProVee System and Zenflow Spring Implant, investigational as a treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Under the policy's definition, investigational technology is not considered medically necessary. The FDA granted premarket approval for both devices in December 2025 and required 60-month post-approval studies for both, and the policy history lists 09/01/2026 as the date the new policy was added.

Get alerts when payers change rules like this one

We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.

Get Blue Cross & Blue Shield of Mississippi alertsPolicy Monitoring is free. No card required.

What to do

Action · 5 steps
01Billing team: before scheduling or billing permanently implanted prostatic stent devices for lower urinary tract symptoms due to BPH, review the member's specific benefit plan language, because the policy guidelines should not be used in lieu of that language.
02The policy considers permanently implanted prostatic stent devices, including the ProVee System and Zenflow Spring Implant, investigational for this use.
03For Federal Employee Program members, FDA-approved devices may not be considered investigational and may be assessed only on the basis of medical necessity.
04Check claims against the policy's Investigational Codes list, which includes 0942T, 0943T, C1889 and L8699, and also the first bladder exam code printed as 40941T in the source.
05The policy notes that its code reference may not be a comprehensive list of procedure codes.

Codes mentioned

C1889L8699

Original notice

Permanently Implanted Prostatic Devices for Benign Prostatic Hyperplasia
bcbsms.com · Always check the source before changing claims.
View original ↗

Related changes

See all Blue Cross & Blue Shield of Mississippi changes →
Three-Dimensional Printed Orthopedic ImplantsMediumNo effective date · Medical PolicySynthetic Cartilage Implants for Joint PainMediumNo effective date · Medical PolicyBrowse every Blue Cross & Blue Shield of Mississippi change in the policy list

Related policy hubs

Blue Cross & Blue Shield of Mississippi policiesUrologyCode C1889Code L8699

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Policy MonitoringPayer policy, prior auth and coding changes, filtered to your saved searchesOIG ScreeningStaff and vendors screened every month against OIG LEIE, SAM.gov and state Medicaid listsPrior Auth LookupKnow if a service needs prior authorization before you schedule itCredentialing TrackerLicenses, CAQH, Medicare revalidation and payer enrollments, with reminders before anything lapsesCompliance CenterKeep your HIPAA program documented and ready to show
Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account